Mediconectar Pharmacy Private Limited
About Mediconectar Pharmacy Private Limited
Data last updated:
Mediconectar Pharmacy Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC262610. Its GSTIN is 09AAICM9874H1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lal Narayan Pratap and Anuj Gangwar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 162 Bank Colony Mandoli Nand Nagari, Delhi, India – 110093.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.55 Cr, a decline of 61% compared to the previous year. For the same year it recorded a net profit of ₹31,392 (net margin 0.1%) and EBITDA of ₹77,353 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mediconectar Pharmacy Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address162 Bank Colony Mandoli Nand Nagari, Delhi, India – 110093
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mediconectar Pharmacy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mediconectar Pharmacy is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Mediconectar Pharmacy Private Limited, buy the company report.
Financials of Mediconectar Pharmacy Private Limited
FY 2023 filings availableMediconectar Pharmacy Private Limited reported revenue of ₹2.55 Cr (down 61% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 61% fall in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77,353 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,392 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mediconectar Pharmacy Private Limited, buy the company report.
Board of directors of Mediconectar Pharmacy Private Limited
Mediconectar Pharmacy has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lal Narayan Pratap Also directs: Cadillac Lifesciences Private Limited, Chitrali Electricals Private Limited, RLV Lifesciences Private Limited and 1 more | Director | 26 Nov 2018 | 7 Years 11 Months | Current |
| Anuj Gangwar Also directs: Oceantg India Private Limited | Director | 23 Dec 2013 | 12 Years 10 Months | Current |
Auditor
Mediconectar Pharmacy Private Limited is audited by MADHAV & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MADHAV & COMPANY | FY 2019 | 022141N |
Shareholding
The shareholding of Mediconectar Pharmacy Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Mediconectar Pharmacy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mediconectar Pharmacy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediconectar Pharmacy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mediconectar Pharmacy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICM9874H1ZQ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mediconectar Pharmacy Private Limited, buy the company report.
Recent activity
Mediconectar Pharmacy Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Anshul Kumar ceased to be Director on 27 Nov 2018.
Frequently asked questions
Mediconectar Pharmacy is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 December 2013 (13+ years old) and is registered under CIN U85100DL2013PTC262610.
Mediconectar Pharmacy has 2 current directors:
- Lal Narayan Pratap - Director
- Anuj Gangwar - Director
The latest financial statements of Mediconectar Pharmacy on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Mediconectar Pharmacy is 09AAICM9874H1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Mediconectar Pharmacy is U85100DL2013PTC262610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediconectar Pharmacy was incorporated on 23 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Anshul Kumar ceased to be Director on 27 Nov 2018. Lal Narayan Pratap was appointed as Director on 26 Nov 2018. Rohit Singh Kumar ceased to be Director on 10 Mar 2015. Mediconectar Pharmacy has 5 board changes on record in total.
The registered office of Mediconectar Pharmacy is at 162 Bank Colony Mandoli Nand Nagari, Delhi, India – 110093.
Mediconectar Pharmacy operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Mediconectar Pharmacy is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.